Lupin launches discomfort relieving generic tablets in US

Shares of Lupin today closed 1.99 per cent higher at Rs 1,060.50 per scrip on BSE.Shares of Lupin today closed 1.99 percent greater at Rs 1,060.50 per scrip on BSE.
NEW DELHI: Drug firm Lupin today stated it’s launched its discomfort relieving Hydrocodone Bitartrate and Acetaminophen tablets within the American market.

The organization has launched Hydrocodone Bitartrate and Acetaminophen tablets USP within the strengths of 5mg/325 mg, 7.5 mg/325 mg and 10mg/325 mg after receiving approval in the US Fda (USFDA), Lupin stated inside a BSE filing.

The business’s method is a normal form of Allergan Sales LLC’s Norco tablets within the same strengths and it is indicated for relief of moderate to moderately severe discomfort, it added.

According to IMS Pad June 2017 data, Hydrocodone Bitartrate and Acetaminophen tablets had annual sales close to USD 710 million.

Shares of Lupin today closed 1.99 percent greater at Rs 1,060.50 per scrip on BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *